COVID-19 accelerates non-adherence and magnifies health inequalitiesNon-adherence to medication has long been a thorn in the side of effective healthcare management – and the Share XCOVID-19 accelerates non-adherence and magnifies health inequalitieshttps://pharmaphorum.com/views-analysis-patients/covid-19-accelerates-non-adherence-and-magnifies-health-inequalities/
AiCure launches “digital biomarker” app for clinical trialsArtificial intelligence company AiCure has launched a digital tool that detects subtle changes in a patient’s condition that Share XAiCure launches “digital biomarker” app for clinical trialshttps://pharmaphorum.com/news/aicure-launches-digital-biomarker-app-for-clinical-trials/
eLucid plans to link Pill Connect device to smart watchesHealth tech company eLucid says it plans to extend the compatibility of its Pill Connect device for medicine Share XeLucid plans to link Pill Connect device to smart watcheshttps://pharmaphorum.com/news/elucid-plans-to-link-pill-connect-device-to-smart-watches/
eLucid gets US patents for smart pill dispenser deviceHealth tech firm eLucid mHealth has been granted a pair of US patents for its recently-launched Pill Connect, Share XeLucid gets US patents for smart pill dispenser devicehttps://pharmaphorum.com/news/elucid-gets-us-patent-for-smart-pill-dispenser-device/
Med tech and adherence: modern ways to tackle an age-old problemMedication adherence is a long-standing problem, but the dawning of the patient-centric age is opening up new ways Share XMed tech and adherence: modern ways to tackle an age-old problemhttps://pharmaphorum.com/views-analysis-digital/med-tech-adherence/
How can pharma companies win the trust of Generation Z?The information age has produced a generation of young people concerned about their health, but distrustful of big Share XHow can pharma companies win the trust of Generation Z?https://pharmaphorum.com/views-and-analysis/how-can-pharma-companies-win-the-trust-generation-z/
Tackling adherence is “only sustainable path to profit”Every year, pharmaceutical companies lose an eye-watering $637bn through medication non-adherence – so why isn’t the industry taking Share XTackling adherence is “only sustainable path to profit”https://pharmaphorum.com/views-analysis-sales-marketing/tackling-adherence-is-only-sustainable-path-to-profit/
Adherence – Don’t Remind Me!The benefits of adherent patients are no secret: better outcomes, a more stable treatment pathway and of course Share XAdherence – Don’t Remind Me!https://pharmaphorum.com/sales-marketing/adherence-dont-remind-me/
Beyond patient centricity – supporting the support networkOur new patient-centric world has already gone “beyond the pill”, and now it’s going beyond the patient. There’s a Share XBeyond patient centricity – supporting the support networkhttps://pharmaphorum.com/views-and-analysis/beyond-patient-centricity-support-network/
